FDA Food and Drug Administration - Search News

FDA, Axsome and migraine

Hosted on MSN · 9h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday. The oral drug, branded Symbravo, was approved for the acute treatment of the condition characterized by recurrent attacks of moderate to severe throbbing and pulsating pain on one side of the head.

Business Insider · 12h

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in

Investing.com on MSN · 11h

FDA approves new migraine treatment SYMBRAVO

NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,

Seeking Alpha on MSN · 11h

Axsome gets FDA approval for Symbravo for migraine

Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo, a combination of meloxicam and rizatriptan,

New non-opioid painkiller Journavx approved by FDA

FDA approves new type of non-opioid pain medication

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is

FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.

New Atlas · 6h

FDA approves new class of painkiller – the first in more than 20 years

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term moderate-to-severe pain in adults. It’s the first of a new class of analgesics to be approved in over 20 years,

This chocolate recall has been upgraded to FDA’s highest risk level

STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...

Moscow-Pullman Daily News30m

New bill introduced to put 10-year pause on certain vaccines

BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...

Biocon Biologics CEO expects core margin improvement, outlines upcoming launches

Alongside margin recovery, Biocon Biologics has also gained market share, with oncology remaining a key focus area.

Hosted on MSN40m

Caroline Lacroix Went From Mistress to Queen

Caroline Lacroix might have been called “The Queen of the Congo”—but the acts she performed to earn her title were utterly despicable.

18hon MSNOpinion

The FDA’s new, same-old food labels demand better obesity solutions

All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

12hOpinion

Do food warning labels actually work? Answering your questions.

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

WISH-TV on MSN10h

FDA redefines ‘healthy’ food labels to help consumers make informed choices

The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...

1d

FDA clears use of Ozempic to protect kidney health

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results